Srikanth P Tripathy
Overview
Explore the profile of Srikanth P Tripathy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
406
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tamilzhalagan S, Justin E, Selvaraj A, Venkateswaran K, Sivakumar A, Chittibabu S, et al.
Front Microbiol
. 2025 Jan;
15:1515627.
PMID: 39845030
Pyrazinamide (PZA) is a key first-line antituberculosis drug that plays an important role in eradicating persister (TB) bacilli and shortening the duration of tuberculosis treatment. However, PZA-resistance is on the...
2.
Kakad U, Khopkar-Kale P, Tripathy S, Bhawalkar J
Br J Clin Pharmacol
. 2024 Dec;
91(2):493-494.
PMID: 39682075
No abstract available.
3.
Deshmukh S, Khopkar-Kale P, Tripathy S, Bhawalkar J
Asian J Psychiatr
. 2024 Nov;
103():104330.
PMID: 39612543
No abstract available.
4.
Babu H, Rachel G, Neogi U, Palaniappan A, Narayanan A, Ponnuraja C, et al.
Metab Brain Dis
. 2024 Nov;
40(1):32.
PMID: 39570517
People living with HIV (PLHIV) are known to be at a higher risk of developing an array of aging-related diseases despite well-adhered combined antiretroviral therapy (cART). The present study aimed...
5.
Tripathy A, Trimbake D, Suryawanshi P, Tripathy S, Gurav Y, Potdar V, et al.
Indian J Med Res
. 2022 Jul;
155(1):136-147.
PMID: 35859440
Background & Objectives: The COVID-19 disease profile in Indian patients has been found to be different from the Western world. Changes in lymphocyte compartment have been correlated with disease course,...
6.
Kumar Shanmugam S, Kumar N, Sembulingam T, Ramalingam S, Selvaraj A, Rajendhiran U, et al.
Microbiol Spectr
. 2022 Apr;
10(3):e0159421.
PMID: 35442078
Current knowledge on resistance-conferring determinants in Mycobacterium tuberculosis is biased toward globally dominant lineages 2 and 4. In contrast, lineages 1 and 3 are predominant in India. In this study,...
7.
Krishnan R, Thiruvengadam K, Jayabal L, Selvaraju S, Watson B, Malaisamy M, et al.
Sci Rep
. 2022 Apr;
12(1):6147.
PMID: 35413979
Climate factors such as dew point temperature, relative humidity and atmospheric temperature may be crucial for the spread of tuberculosis. This study was conducted for the first time to investigate...
8.
Shanmugam S, Bachmann N, Martinez E, Menon R, Narendran G, Narayanan S, et al.
Int J Infect Dis
. 2021 Mar;
113 Suppl 1:S43-S47.
PMID: 33741489
Introduction: Differentiation between relapse and reinfection in cases with tuberculosis (TB) recurrence has important implications for public health, especially in patients with human immunodeficiency virus (HIV) co-infection. We compared Mycobacterial...
9.
Saravanan P, Azger Dusthackeer V, Rajmani R, Mahizhaveni B, Nirmal C, Rajadas S, et al.
Sci Rep
. 2021 Jan;
11(1):1029.
PMID: 33441878
Tuberculosis (TB) is an infectious disease caused by the bacillus Mycobacterium tuberculosis (Mtb). The present work reports the design and synthesis of a hybrid of the precursors of rifampicin and...
10.
Sivakumar S, Chandramohan Y, Kathamuthu G, Sekar G, Kandhasamy D, Padmanaban V, et al.
BMC Infect Dis
. 2020 Nov;
20(1):894.
PMID: 33243148
Background: Tuberculosis (TB) though primarily affects the lungs it may also affect the other parts of the body and referred as extra pulmonary (EPTB). This study is focused on understanding...